Closing Figures: GoodRx Holdings Inc (GDRX)’s Positive Finish at 6.70, Up 1.52

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

After finishing at $6.60 in the prior trading day, GoodRx Holdings Inc (NASDAQ: GDRX) closed at $6.70, up 1.52%. In other words, the price has increased by $1.52 from its previous closing price. On the day, 1.01 million shares were traded. GDRX stock price reached its highest trading level at $6.86 during the session, while it also had its lowest trading level at $6.565.

Ratios:

Our goal is to gain a better understanding of GDRX by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.71 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.06. For the most recent quarter (mrq), Quick Ratio is recorded 6.29 and its Current Ratio is at 6.29. In the meantime, Its Debt-to-Equity ratio is 1.13 whereas as Long-Term Debt/Eq ratio is at 1.11.

On March 25, 2024, Wells Fargo Upgraded its rating to Overweight which previously was Equal Weight and also upped its target price recommendation from $7.50 to $10.

JP Morgan Upgraded its Neutral to Overweight on March 01, 2024, whereas the target price for the stock was revised from $7 to $10.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 30 ’23 when Wagner Scott bought 21,652 shares for $5.76 per share. The transaction valued at 124,806 led to the insider holds 182,900 shares of the business.

Wagner Scott bought 26,348 shares of GDRX for $155,482 on Nov 29 ’23. The insider now owns 161,248 shares after completing the transaction at $5.90 per share. On Nov 28 ’23, another insider, Wagner Scott, who serves as the insider of the company, bought 4,157 shares for $6.00 each. As a result, the insider paid 24,940 and bolstered with 134,900 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GDRX now has a Market Capitalization of 2513873408 and an Enterprise Value of 3044704000. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.29 while its Price-to-Book (P/B) ratio in mrq is 3.98. Its current Enterprise Value per Revenue stands at 4.058 whereas that against EBITDA is 45.449.

Stock Price History:

The Beta on a monthly basis for GDRX is 1.36, which has changed by 0.321499 over the last 52 weeks, in comparison to a change of 0.2704494 over the same period for the S&P500. Over the past 52 weeks, GDRX has reached a high of $9.37, while it has fallen to a 52-week low of $4.14. The 50-Day Moving Average of the stock is -4.64%, while the 200-Day Moving Average is calculated to be 5.02%.

Shares Statistics:

The stock has traded on average 1.42M shares per day over the past 3-months and 1613300 shares per day over the last 10 days, according to various share statistics. A total of 92.36M shares are outstanding, with a floating share count of 77.39M. Insiders hold about 79.36% of the company’s shares, while institutions hold 14.44% stake in the company. Shares short for GDRX as of 1713139200 were 8800356 with a Short Ratio of 5.99, compared to 1710460800 on 9852345. Therefore, it implies a Short% of Shares Outstanding of 8800356 and a Short% of Float of 10.569999.

Earnings Estimates

A comprehensive evaluation of GoodRx Holdings Inc (GDRX) is underway, with the input of 15.0 analysts contributing to its current rating.On average, analysts expect EPS of $0.09 for the current quarter, with a high estimate of $0.11 and a low estimate of $0.08, while EPS last year was $0.07. The consensus estimate for the next quarter is $0.09, with high estimates of $0.12 and low estimates of $0.08.

Analysts are recommending an EPS of between $0.46 and $0.32 for the fiscal current year, implying an average EPS of $0.37. EPS for the following year is $0.45, with 16.0 analysts recommending between $0.57 and $0.36.

Revenue Estimates

16 analysts predict $199.96M in revenue for the current quarter. It ranges from a high estimate of $202.4M to a low estimate of $197M. As of the current estimate, GoodRx Holdings Inc’s year-ago sales were $189.68MFor the next quarter, 16 analysts are estimating revenue of $201.19M. There is a high estimate of $205.34M for the next quarter, whereas the lowest estimate is $198M.

A total of 19 analysts have provided revenue estimates for GDRX’s current fiscal year. The highest revenue estimate was $812.72M, while the lowest revenue estimate was $800M, resulting in an average revenue estimate of $803.96M. In the same quarter a year ago, actual revenue was $750.26MBased on 19 analysts’ estimates, the company’s revenue will be $864.95M in the next fiscal year. The high estimate is $929.8M and the low estimate is $839.8M.

Most Popular

[the_ad id="945"]